C180SE CO2 Incubator | Peking University

Advancing Cancer Immunotherapy Research at Peking University

The C180SE High Heat Sterilization CO2 Incubator has become an essential tool in a leading research group at the Peking University Health Science Center (PKUHSC), focusing on the development of advanced cancer immunotherapies. The team investigates tumor-immune interactions, aiming to identify novel therapeutic targets for enhancing immune response in cancer patients.

The C180SE incubator ensures a sterile and stable environment, offering precise temperature control (±0.1°C) and consistent CO2 levels, critical for culturing immune and tumor cells. Its 140°C high heat sterilization minimizes contamination risks, maintaining the integrity of sensitive cell cultures. With spacious chamber capacity and uniform conditions, the incubator supports experiments requiring reproducibility and high cell viability.